BRCA2 and breast carcinoma: Accordingly, we investigated the effects on DSB repair in budding yeast of two HsRAD52 variants identified in African-American women with breast cancer, HsRAD52-G59R and HsRAD52-S346X; the latter recently reported to attenuate the pathogenicity of BRCA2 mutations in breast cancer [30].